Brook Preloader

Werner Lanthaler, PhD

Werner is the CEO at Evotec, a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.

  • Evotec, CEO
  • Chief Financial Officer and Business Development and Marketing & Sales at Intercell AG in Vienna
  • Contributed to gaining the product approval of Intercell’s Japanese Encephalitis vaccine and its Initial Public Offering on the Vienna Stock Exchange in 2005
  • Director of the Federation of Austrian Industry and as Senior Management Consultant at McKinsey & Company
  • Doctorate in Economics from Vienna University, Master’s degrees from Harvard and a degree in Psychology